Brexit: Where Things Stand For Medtech
Executive Summary
UK and EU leaders announced some progress on Brexit this week, establishing a conditional transition period after the UK exits the Union in 2019. But that does not resolve many questions and concerns in the medtech space about what's to come. Here is a comprehensive look at where things stand for medtech, based a discussion from this week's Device Week podcast.
You may also be interested in...
UK Medtechs Get A Touch More Certainty With Brexit Transition Agreement
With the UK scheduled to leave the EU one year, the UK medtech and lifesciences industries were becoming increasingly concerned about the government's lack ofplanning and the risk of being left high and dry in the post-Brexit environment. But the UK has bought more time now that the EU agreed to a withdrawal transition phase until the end of 2020. There are potentially meaningful positives in the agreement for medtechs on either side of the English Channel.
Device Week, March 22, 2018 – Brexit, And Where Things Stand For Medtech
On this week's podcast, a deep dive into what is happening with Brexit, and what it means for the medtech sector.
Brexit To Force Large-Scale Review Of Medtech Contractual Arrangements Throughout EU
UK companies, and firms in the EU dealing with them, need to be prepared to renegotiate their relationships in the context of Brexit, lawyer Alison Dennis tells the sector.